PrescribeWellness Takes Steps to Ensure Medication Synchronization Tools Are Available to All of Its Pharmacy Customers November 18, 2014 09:06 AM Eastern Standard Time ALISO VIEJO, Calif.–(BUSINESS WIRE)–PrescribeWellness, the SaaS, cloud-based platform that delivers efficient patient communications and actionable solutions to community pharmacists, can now ensure access to its medication synchronization tools for all of
HERSHEY, Pa. — A new retail concept from The Hershey Co. made its debut at food and drug retailer Winn-Dixie. Hershey’s "Candy Experience" concept brings the candy aisle into the front of Winn-Dixie’s Baton Rouge store. Hershey said Wednesday that the store-within-a-store concept, dubbed the "Candy Experience," replaced the traditional candy aisle at Winn-Dixie’s newly
RHINEBECK, N.Y. — Topical BioMedics Inc. has introduced a new Topricin floor display for retailers. The company said Wednesday that the four-color unit sports a small footprint yet holds multiple combinations of any Topricin topical pain relief formula and size, providing maximum flexibility, exposure and sales. Made of heavy-duty cardboard, the display stands 56 inches
NASHVILLE, Tenn. — Emdeon Inc. has entered into an agreement to acquire Change Healthcare, a provider of health care consumer engagement and transparency solutions Emdeon, a Nashville, Tenn.-based provider of revenue and payment cycle management and clinical information exchange solutions, said Wednesday that under the deal it will buy Change Healthcare for about $135 million
ST. LOUIS — Veteran Energizer Holdings Inc. executive Lou Martire plans to retire next year after more than four decades at the company. In an e-mail note Tuesday to industry colleagues, Martire said his retirement will go into effect in April 2015 and that he will continue in his duties as vice president of trade
NEW YORK — Pfizer Inc. has released Trumenba, a meningococcal group B vaccine, to pharmacies and other health care providers in the United States. Pfizer said Tuesday that Trumenba marks the first and only Food and Drug Adminstration-approved vaccine for active immunization to prevent serogroup B meningococcal meningitis in people ages 10 to 25. The
PHILADELPHIA — Pharmaceutical industry veteran Ernest Sabo plans to retire from Lannett Co. next year. The generic pharmaceutical company said late Monday that Sabo, vice president of regulatory affairs and chief compliance officer, is slated to retire effective Jan. 2, 2015. Sabo joined Lannett in March 2005 as director of quality assurance (QA) and in
TORONTO — Teva Canada Ltd. has released a generic version of Pfizer Inc.’s arthritis pain drug Celebrex (celecoxib). Teva said Monday that its generic celecoxib product, approved by Health Canada, is available now in pharmacies across Canada. Celecoxib is indicated for the symptomatic relief associated with osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, as well as
NEW YORK — Cosmetics and beauty care giant Revlon Inc. has relaunched its brand with a global tagline, its first in more than a decade. Dubbed "Revlon Love Is On," the new brand identity focuses on "inspiring love and connecting with people around the world on an emotional level" and will be incorporated into every
WASHINGTON — Patrick Lockwood-Taylor, vice president of personal health care for North America and digestive wellness design at Procter & Gamble Co., has been elected as chairman of the Consumer Healthcare Products Association (CHPA). As CHPA chairman, Lockwood-Taylor succeeds James Mackey, senior vice president at Bayer HealthCare LLC. The P&G executive was elected during CHPA’s fall
FORT WORTH, Texas — Galderma Laboratories has unveiled a new look for its Cetaphil RestoraDerm line of eczema-soothing products. Galderma said Monday that the RestoraDerm packaging now highlights the condition in the products’ new names, Cetaphil RestoraDerm Eczema Calming Body Wash and Cetaphil RestoraDerm Eczema Calming Moisturizer. The updated labels will provide a better guide
DUBLIN — Actavis PLC is acquiring Allergan Inc. in a transaction valued at about $66 billion. The combination will create one of the top-10 global pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than $23 billion anticipated in 2015. The transaction has been unanimously approved by the boards of Actavis
PRINCETON, N.J. — The Food and Drug Administration is reclassifying methylphenidate hydrochloride extended-release tablets from Kremers Urban Pharmaceuticals Inc. as the agency seeks more bioequivalence information. Kremers Urban said Friday that the FDA is requesting an additional bioequivalence study based on recently issued draft guidance to confirm the therapeutic equivalence of the company’s methylphenidate hydrochloride
CINCINNATI and OMAHA, Neb. — Conglomerate Berkshire Hathaway Inc. has agreed to acquire the Duracell battery business from Procter & Gamble Co. The companies said Thursday that the deal, encompassing roughly $6.5 billion in cash and stock, is expected to close in the second half of 2015 pending regulatory approvals and other customary closing conditions.
